文献速递妇科

II型子宫内膜癌的微创手术入路:是否明智且安全?

Minimally Invasive Approach in Type II Endometrial Cancer: Is It Wise and Safe?
PubMed 文献 · J Minim Invasive Gynecol · 2017-01-05

该回顾性队列研究比较了II型子宫内膜癌患者接受微创手术(MIS组141例)与开腹手术(LPT组142例)的分期与生存结局。两组基线特征和围手术期数据相当,LPT组手术时间更长、MIS组住院时间更短;MIS组早期 stage 比例更高,LPT组复发率及复发数量更高;两组无进展生存和总生存无显著差异。作者认为由专家手术时高危组织学亚型不应视为MIS禁忌,但需进一步前瞻性随机研究。

要点

  • II型子宫内膜癌MIS组与LPT组基线特征和围手术期数据相当,仅手术时间和住院时间有差异。
  • LPT组复发率及复发数量高于MIS组,但两组无进展生存和总生存无显著差异。
  • 作者认为由专家手术时高危组织学亚型不应视为MIS的禁忌证。

核心结论

  • II型子宫内膜癌患者接受MIS子宫切除术的并发症更少,生存结局与开腹手术相似。
  • 由专家手术时,高危组织学亚型不应视为MIS的禁忌证。
  • 需进一步前瞻性随机研究来明确MIS在早期II型子宫内膜癌中的安全性和可行性。

研究设计与样本

  • 回顾性队列研究(加拿大任务组分类II-2)。
  • 共纳入283例临床FIGO I-II期、术前检查提示早期病变而病理分期为III期的II型子宫内膜癌患者。
  • LPT组142例行开腹子宫切除术,MIS组141例行微创手术。
  • 研究机构为罗马圣心天主教大学、瓦雷泽因苏布里亚大学和罗马Regina Elena国家癌症研究所。

主要发现

  • 两组基线特征和围手术期数据相当,仅手术时间LPT组长于MIS组(p < .001),住院时间MIS组短于LPT组。
  • 两组病理特征除肌层浸润和盆腔淋巴结阳性率外无差异,MIS组早期stage比例更高(p < .001)。
  • 总体人群中,LPT组复发率及复发数量高于MIS组(p < .001),复发部位也有显著差异。
  • 两组无进展生存和总生存无显著差异。

临床怎么用

  • 作者认为,由专家手术时,高危组织学亚型不应视为MIS的禁忌证。
  • 原文未据此给出其他临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: To compare perioperative and survival outcomes in patients with type II endometrial cancer surgically staged by a minimally invasive surgery (MIS) approach and those surgically staged by laparotomy. DESIGN: Retrospective cohort study (Canadian Task Force classification II-2). SETTING: Catholic University of the Sacred Heart of Rome, University of Insubria, Varese and "Regina Elena" National Cancer Institute of Rome. PATIENTS: A total of 283 patients with type II endometrial cancer in clinical International Federation of Gynecology and Obstetrics stage I-II and pathological stage III with apparent early-stage disease detected on preoperative instrumental examination. INTERVENTIONS: Baseline features and perioperative data were evaluated in 142 patients who underwent hysterectomy via open surgery (laparotomy [LPT] group) and 141 patients who did so via a minimally invasive approach (MIS group). MEASUREMENTS AND MAIN RESULTS: The 2 groups were comparable in terms of baseline features and perioperative data except for operative time, which was longer in the LPT group (p < .001) and hospital stay, which was shorter in the MIS group. There were no between-group differences in pathological features, except for myometrial invasion and the rate of positive pelvic lymph nodes. Therefore, we obtained a higher number of early stages in the MIS group (p < .001). In the overall population, significant differences were observed in the recurrence rate, number, and site of relapses, with a higher recurrence rate and number in the LPT group (p < .001). Progression-free and overall survival were not significantly different in the 2 groups. CONCLUSION: Women with type II endometrial cancer submitted to MIS for hysterectomy experienced fewer complications and similar survival outcomes compared with those who underwent open surgery. When managed by an expert surgeon, a high-risk histological subtype should not be considered a contraindication for MIS. Further prospectively randomized studies are needed to definitively evaluate the safety and feasibility of MIS in early-stage type II endometrial cancer.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Monterossi G, Ghezzi F, Vizza E, et al. Minimally Invasive Approach in Type II Endometrial Cancer: Is It Wise and Safe? J Minim Invasive Gynecol. 2017. PMID: 28065812. doi:10.1016/j.jmig.2016.12.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。